Literature DB >> 16010647

Chronic pain in end-stage renal disease.

Sara N Davison1.   

Abstract

A growing body of literature has shown that chronic pain is common for patients with end-stage renal disease (ESRD), is typically moderate or severe, and impacts virtually every aspect of health-related quality of life. Unfortunately, there is a lack of clinical and research focus in this area in nephrology, and pain in ESRD is undertreated. This article will review the epidemiology of chronic pain in ESRD, discuss basic principles of pain assessment and management, and highlight some of the challenges in pain management in ESRD with the hope of guiding health professionals in the effective management of pain in patients with ESRD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010647     DOI: 10.1016/j.ackd.2005.03.008

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  5 in total

Review 1.  Opioid Management in Older Adults with Chronic Kidney Disease: A Review.

Authors:  Montgomery T Owsiany; Chelsea E Hawley; Laura K Triantafylidis; Julie M Paik
Journal:  Am J Med       Date:  2019-07-08       Impact factor: 4.965

2.  Calcium, parathyroid hormone, and vitamin D: major determinants of chronic pain in hemodialysis patients.

Authors:  Eliezer Golan; Isabelle Haggiag; Pnina Os; Jacques Bernheim
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 8.237

3.  Comorbidity phenotypes and risk of mortality in patients with osteoarthritis in the UK: a latent class analysis.

Authors:  Dawit T Zemedikun; Helena Lee; Krishnarajah Nirantharakumar; Karim Raza; Joht Singh Chandan; Janet M Lord; Thomas A Jackson
Journal:  Arthritis Res Ther       Date:  2022-10-13       Impact factor: 5.606

4.  Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine.

Authors:  Miklós Palkovits; Katarína Šebeková; Kristina Simon Klenovics; Anton Kebis; Gholamreza Fazeli; Udo Bahner; August Heidland
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

5.  Cannabinoids versus placebo or no intervention for pain: protocol for a systematic review with meta-analysis and trial sequential analysis.

Authors:  Jehad Ahmad Barakji; Steven Kwasi Korang; Joshua Feinberg; Mathias Maagard; Christian Gluud; Ole Mathiesen; Janus Christian Jakobsen
Journal:  BMJ Open       Date:  2019-10-31       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.